Arama Sonuçları - Kramer Benjamin

Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches Yazar: Lawrence David, Kramer Benjamin, Looby Michael, Renard Didier, Morris David, Stanski Donald R

Tam Metin Erişim

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium Yazar: Owen Roger, Piggott Simon, Jack Damon, Ramos-Barbon David, Vogelmeier Claus, Higgins Mark, Kramer Benjamin

Tam Metin Erişim

Efficacy and safety of indacaterol 150 <it>μ</it>g once-daily in COPD: a double-blind, randomised, 12-week study Yazar: Piggott Simon, Jack Damon, Prasad Niyati, Siler Thomas, Feldman Gregory, Owen Roger, Higgins Mark, Kramer Benjamin

Tam Metin Erişim

TRAIL receptor I (<it>DR4</it>) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients Yazar: Körner Christian, Riesner Katarina, Krämer Benjamin, Eisenhardt Marianne, Glässner Andreas, Wolter Franziska, Berg Thomas, Müller Tobias, Sauerbruch Tilman, Nattermann Jacob, Spengler Ulrich, Nischalke Hans

Tam Metin Erişim

Questions of Communicative Change and Continuity

“…Krämer, Benjamin…”
Tam Metin Erişim